| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.05 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |